Aflac ST1001 Prolonged Isotretinoin

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Neuroblastoma
Interventions
DRUG

Isotretinoin

\>12 kg: 160 mg/m2/day, given PO, divided BID \<=12 kg: 5.33 mg/kg/day, given PO, dividied BID doses given days 1-14 of 28 day cycle for 24 consecutive cycles

Trial Locations (1)

30322

Children's Healthcare of Atlanta, Atlanta

Sponsors
All Listed Sponsors
collaborator

Children's Healthcare of Atlanta

OTHER

lead

Emory University

OTHER